Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Phase I/II Clinical Trial of CpG-Activated Whole Cell Vaccine in Mantle Cell Lymphoma (MCL): Results in Safety and Efficacy from Planned Interim Analysis

Blood (2015) 126 (23): 1536.

https://doi.org/10.1182/blood.V126.23.1536.1536

Published: 2015

Journal Articles

Induction Of In Vivo Oligoclonal T Cell Expansion and Specific In Vitro T Cell Responses Following K562/GM-CSF Vaccination Of MDS Patients

Gabrielle Prince, Chris Thoburn, Erica D. Warlick, MD, Allan D. Hess, PhD, B. Douglas Smith, MD

Blood (2013) 122 (21): 2811.

https://doi.org/10.1182/blood.V122.21.2811.2811

Published: 2013

Journal Articles

Cloning of the Full-Length Gene of a Novel Human Acute Monocytic Leukemia Associated Antigen (MLAA-22) and Characterization of Its Functions

Wanggang Zhang, Liufang Gu, Aili He, Xingmei Cao, Yinxia Chen, Xiaorong Ma, Jie Liu, Pengyu Zhang

Blood (2011) 118 (21): 1399.

https://doi.org/10.1182/blood.V118.21.1399.1399

Published: 2011

Journal Articles

CD137 Identifies a Population of Regulatory T Cells That Inhibit Anti-Tumor Immune Responses In Adoptive Immunotherapy

Matthew J Goldstein, BA, Holbrook E Kohrt, MD, Roch Houot, MD/PhD, Bindu Varghese, PhD, Jack T Lin, PhD, Erica Swanson, BA, Ronald Levy, MD

Blood (2010) 116 (21): 2093.

https://doi.org/10.1182/blood.V116.21.2093.2093

Published: 2010

Journal Articles

Adoptive Cell Therapy for Lymphoma: Use of CpG-Loaded Tumor Cells to Generate Potent Anti-Tumor CD4 T Cell Immunity.

Matthew J Goldstein, Bindu Varghese, PhD, Ranjani Rajapaksa, PhD, Joshua Brody, MD, Shoshana Levy, PhD, Ronald Levy, MD

Blood (2009) 114 (22): 929.

https://doi.org/10.1182/blood.V114.22.929.929

Published: 2009

Journal Articles

Myeloid Leukemic Blasts Use the Endogenous HLA Class I Antigen Processing Machinery for Peptide Loading Onto HLA Class II Molecules: Implications for Immunotherapy.

Marvin M. van Luijn, Martine E.D. Chamuleau, MD, PhD, Maaike E. Ressing, PhD, Emmanuel J.H.J. Wiertz, PhD, Suzanne Ostrand-Rosenberg, PhD, Yuri Souwer, Adri Zevenbergen, Gert J. Ossenkoppele, MD, PhD, Arjan A. van de Loosdrecht, MD, PhD, S. Marieke van Ham, PhD

Blood (2009) 114 (22): 3114.

https://doi.org/10.1182/blood.V114.22.3114.3114

Published: 2009

Journal Articles

A CpG-Activated Whole-Cell Vaccine ‘Boost’ Enhances the Anti- Lymphoma Efficacy of Immunotransplant

Joshua Brody, MD, Matthew J. Goldstein, Ronald Levy, MD

Blood (2008) 112 (11): 3627.

https://doi.org/10.1182/blood.V112.11.3627.3627

Published: 2008

Journal Articles

TLR-9 Activated Lymphoma B Cells Induce Anti-Tumor Immunity in a Murine Model

Matthew J. Goldstein, Joshua Brody, MD, Ronald Levy, MD

Blood (2008) 112 (11): 4992.

https://doi.org/10.1182/blood.V112.11.4992.4992

Published: 2008

Journal Articles

IL-2/B7.1 Fusagene Transduction of AML Blasts by a Self-Inactivating Lentiviral Vector Stimulates T Cell Responses in Vitro: A Strategy To Generate Whole Cell Vaccines for AML.

Lucas Chan, PhD, Nicola Hardwick, MPhil, Dave Darling, PhD, Joanna Galea-Lauri, PhD, Joop Gäken, PhD, Stephen Devereux, MD PhD, Mike Kemeny, PhD FRCPath, Ghulam Mufti, MD PhD DSc FRCP, Farzin Farzaneh, DPhil FRCPath

Blood (2004) 104 (11): 5275.

https://doi.org/10.1182/blood.V104.11.5275.5275

Published: 2004

Journal Articles

DNA Immunization Against Melanoma Antigens Enhances Tumor Immunity in Mouse Models of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

Adi Diab, MD, Miguel-Angel Perales, MD, Adam Cohen, MD, Vanessa M. Hubbard, Jeff Eng, Deonka Huggins, Manuel Engelhorn, PhD, Jose A. Guevarra, MD, Onder Alpdogan, MD, Jedd D. Wolchok, MD, PhD, Adam Kochman, Alan N. Houghton, MD, Marcel van den Brink, MD, PhD

Blood (2004) 104 (11): 304.

https://doi.org/10.1182/blood.V104.11.304.304

Published: 2004

NARROW

Phase I/II Clinical Trial of CpG-Activated Whole Cell Vaccine in Mantle Cell Lymphoma (MCL): Results in Safety and Efficacy from Planned Interim Analysis

Induction Of In Vivo Oligoclonal T Cell Expansion and Specific In Vitro T Cell Responses Following K562/GM-CSF Vaccination Of MDS Patients

Cloning of the Full-Length Gene of a Novel Human Acute Monocytic Leukemia Associated Antigen (MLAA-22) and Characterization of Its Functions

CD137 Identifies a Population of Regulatory T Cells That Inhibit Anti-Tumor Immune Responses In Adoptive Immunotherapy

Adoptive Cell Therapy for Lymphoma: Use of CpG-Loaded Tumor Cells to Generate Potent Anti-Tumor CD4 T Cell Immunity.

Myeloid Leukemic Blasts Use the Endogenous HLA Class I Antigen Processing Machinery for Peptide Loading Onto HLA Class II Molecules: Implications for Immunotherapy.

A CpG-Activated Whole-Cell Vaccine ‘Boost’ Enhances the Anti- Lymphoma Efficacy of Immunotransplant

TLR-9 Activated Lymphoma B Cells Induce Anti-Tumor Immunity in a Murine Model

IL-2/B7.1 Fusagene Transduction of AML Blasts by a Self-Inactivating Lentiviral Vector Stimulates T Cell Responses in Vitro: A Strategy To Generate Whole Cell Vaccines for AML.

DNA Immunization Against Melanoma Antigens Enhances Tumor Immunity in Mouse Models of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only